Lang, S.; Frömming, A.; Walter, N.; Freigang, V.; Neumann, C.; Loibl, M.; Ehrenschwender, M.; Alt, V.; Rupp, M.
Is There a Difference in Clinical Features, Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Healthcare-Associated and Community-Acquired Vertebral Osteomyelitis? Antibiotics 2021, 10, 1410.
https://doi.org/10.3390/antibiotics10111410
AMA Style
Lang S, Frömming A, Walter N, Freigang V, Neumann C, Loibl M, Ehrenschwender M, Alt V, Rupp M.
Is There a Difference in Clinical Features, Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Healthcare-Associated and Community-Acquired Vertebral Osteomyelitis? Antibiotics. 2021; 10(11):1410.
https://doi.org/10.3390/antibiotics10111410
Chicago/Turabian Style
Lang, Siegmund, Astrid Frömming, Nike Walter, Viola Freigang, Carsten Neumann, Markus Loibl, Martin Ehrenschwender, Volker Alt, and Markus Rupp.
2021. "Is There a Difference in Clinical Features, Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Healthcare-Associated and Community-Acquired Vertebral Osteomyelitis?" Antibiotics 10, no. 11: 1410.
https://doi.org/10.3390/antibiotics10111410
APA Style
Lang, S., Frömming, A., Walter, N., Freigang, V., Neumann, C., Loibl, M., Ehrenschwender, M., Alt, V., & Rupp, M.
(2021). Is There a Difference in Clinical Features, Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Healthcare-Associated and Community-Acquired Vertebral Osteomyelitis? Antibiotics, 10(11), 1410.
https://doi.org/10.3390/antibiotics10111410
